Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05253131
Title Trial of Selumetinib and AZD5153 With Durvalumab for Sarcomas
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.